Huang, C., Chung, Y., Wu, S., Wang, H., Lin, C., Yang, T., . . . Chang, Z. (2024). Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK. Communications Biology, 7(1), 1. https://doi.org/10.1038/s42003-024-06547-1
Chicago Style (17th ed.) CitationHuang, Chang-Yu, Yin-Hsuan Chung, Sheng-Yang Wu, Hsin-Yen Wang, Chih-Yu Lin, Tsung-Jung Yang, Jim-Min Fang, Chun-Mei Hu, and Zee-Fen Chang. "Glutathione Determines Chronic Myeloid Leukemia Vulnerability to an Inhibitor of CMPK and TMPK." Communications Biology 7, no. 1 (2024): 1. https://doi.org/10.1038/s42003-024-06547-1.
MLA (9th ed.) CitationHuang, Chang-Yu, et al. "Glutathione Determines Chronic Myeloid Leukemia Vulnerability to an Inhibitor of CMPK and TMPK." Communications Biology, vol. 7, no. 1, 2024, p. 1, https://doi.org/10.1038/s42003-024-06547-1.